Andreas Busch

Andreas Busch

Company: Cyclerion Therapeutics

Job title: Chief Scientific Officer

Seminars:

Moderated Discussion – What Are the Possible Therapeutic Options for Different Phenotypes? 9:45 am

Read more

day: Day Two

Identification of a HFpEF Subpopulation Sensitive to Stimulation of the Soluble Guanylate 8:15 am

Assess the heterogeneity and numerous comorbidities of the general HFpEF population Understand how the pathophysiology of distinct patient sub-population may help to identify specific treatment options Identify an important HFpEF subpopulation where a specific treatment option potentially addresses the specific pathophysiology of this populationRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.